Skip to main content
logo
Cocrystal Pharma logo
Cocrystal Pharma, Inc. (COCP)
NASDAQ: COCP · Real-Time Price · USD
1.070
0.00 (0.00%)
Oct 9, 2026, 4:00 PM EDT - Market closed

Cocrystal Pharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
211321181663
Market Cap Growth
61.03%-34.34%17.29%10.34%-74.94%-32.06%
Enterprise Value
2079-12-262
Last Close Price
1.070.982.021.721.957.80

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
14.132.132.160.660.400.82
P/TBV Ratio
19.742.132.160.660.401.08

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
1.280.240.190.070.010.01
Net Debt / Equity Ratio
-0.79-0.87-0.85-0.93-0.93-0.75
Net Debt / EBITDA Ratio
0.080.620.451.172.054.15
Net Debt / FCF Ratio
0.100.670.491.661.714.56
Quick Ratio
1.113.504.568.3531.1438.00
Current Ratio
1.243.684.778.9233.0438.40
Return on Equity (ROE)
-311.68%-111.40%-97.50%-54.54%-66.32%-21.81%
Return on Assets (ROA)
-96.07%-48.66%-49.98%-36.68%-18.86%-13.30%
Return on Capital Employed (ROCE)
-497.30%-120.20%-162.10%-75.60%-45.80%-18.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-48.22%-65.44%-85.17%-102.64%-244.58%-22.39%
FCF Yield
-38.65%-60.80%-80.25%-84.38%-135.46%-20.16%
Buyback Yield / Dilution
-28.73%-10.97%-5.42%-18.52%-10.58%-60.04%
SEC Filings: 10-K · 10-Q